Clinical Trial Update: Trial of Decitabine in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial of decitabine in patients with acute myeloid leukemia or myelodysplastic syndrome has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Dacogen (decitabine)

Snippet

Sponsor: Eisai Inc. | Conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2011-08-02